Successful Clinical Outcomes start with unlocking your Biomarker Data.
Learn how PerkinElmer™ Signals Translational has helped Bristol Myers Squibb (BMS) with biomarker discovery and patient stratification whilst keeping the focus on F.A.I.R guidelines (Findable, Accessible, Interoperable, Reusable).
Watch this on-demand webinar to see how PerkinElmer™ Signals Translational can support your biomarker projects via:
- Seamless data preparation and access for cross-study analysis
- Search and aggregate study data(s) on the fly to create ad-hoc cohorts
- Fully Integrated Translational Analytics (Powered by TIBCO Spotfire)
- A collaborative framework for effective sharing of data, analytics and your biomarker driven insights